GGMC Announces New CEO and Celebrates Outgoing Leader
![](https://globalgenomics.org/wp-content/uploads/2024/06/ggmc-new-ceo-announcement3-1024x576.jpg)
The Global Genomic Medicine Collaborative (GGMC) is announcing a significant leadership transition. After dedicated service to our organization, Tejinder “Teji” K. Rakhra-Burris, our esteemed President & CEO, will step down from her role to embark on new endeavors. We are pleased to announce Grant Wood, a highly accomplished leader in technology and genomics, will assume the role of CEO effective July 1, 2024.
“I am honored and energized to lead GGMC into its next chapter,” said Wood. “I believe that genomics holds the key to transforming healthcare, and GGMC is uniquely positioned to drive that transformation. I look forward to working with the talented team at GGMC and our partners around the world to advance our mission and make a real difference in people’s lives.”
Wood brings a wealth of experience to GGMC, having served on numerous committees and leading key initiatives since 2014. He has a deep understanding of the organization and a strong vision for its future.
“Grant’s expertise, passion, and collaborative spirit make him an excellent choice to lead GGMC,” said Vajira Dissanayake, GGMC Chair & President. “We are confident that he will build on our legacy of excellence and drive us forward.”
Honoring Teji K. Rakhra-Burris
The GGMC community also extends its deepest gratitude to outgoing CEO Teji K. Rakhra-Burris for her transformative leadership. During her tenure, GGMC has experienced significant growth and made important strides in advancing genomic medicine globally.
“It has been a privilege to serve as CEO of GGMC,” said Rakhra-Burris. “I am proud to have worked with such a dedicated team to build a strong foundation that enabled what we have accomplished together. I am confident that GGMC will continue to thrive under Grant’s leadership.”
Rakhra-Burris’s vision and dedication have helped GGMC expand its reach, establish new partnerships, and advance its mission to improve global health through genomic medicine. She will be missed, but her legacy will continue to inspire and guide GGMC’s work.
A Bright Future
As GGMC embarks on this new chapter, we are filled with excitement and optimism for the future. With Grant Wood at the helm, we are confident that GGMC will continue to lead the way in advancing genomic medicine and improving human health.
About Grant Wood
Grant Wood is an executive technologist with extensive experience in designing and developing innovative healthcare systems, with a focus on precision medicine. He has been an active member of GGMC since 2014, serving on numerous committees and leading key initiatives. Wood is also involved in several other prominent organizations in the technology and genomics space, including Health Level 7 International (HL7), Global Alliance for Genomics and Health (GA4GH), AlphaNet, CDC National Family Health History Group, and other various projects in the field of clinical genomics implementation and innovation.
About GGMC
The Global Genomic Medicine Collaborative (GGMC) is a non-profit organization dedicated to advancing genomic medicine globally. GGMC works with partners around the world to accelerate the translation of genomic research into clinical practice, improve patient care, and reduce health disparities.
Please join us in welcoming Grant Wood as our new CEO and thanking Teji K. Rakhra-Burris for her outstanding service to GGMC. We look forward to a bright future together.